LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | AZD-6482 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6084 | 5905 | 1.0297 | 1.0278 |
MCF7 | AT-7519 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5420 | 5445 | 0.9987 | 0.9994 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4267 | 5905 | 0.7211 | 0.7069 |
MCF7 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1958 | 5445 | 0.3614 | 0.1917 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6297 | 5905 | 1.0662 | 1.0623 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5996 | 5905 | 1.0155 | 1.0149 |
MCF7 | Sorafenib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5186 | 5445 | 0.9513 | 0.9475 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3839 | 5905 | 0.6494 | 0.6252 |
MCF7 | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 1560 | 5905 | 0.2644 | 0.0573 |
MCF7 | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5983 | 5445 | 1.1007 | 1.1009 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5239 | 5905 | 0.8877 | 0.8892 |
MCF7 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1577 | 5445 | 0.2898 | 0.0624 |
MCF7 | Neratinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3737 | 5905 | 0.6332 | 0.6068 |
MCF7 | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3786 | 5445 | 0.6951 | 0.6611 |
MCF7 | SB590885 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5303 | 5905 | 0.8986 | 0.9003 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6450 | 5445 | 1.1889 | 1.1853 |
MCF7 | Alvocidib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1631 | 5445 | 0.2990 | 0.0802 |
MCF7 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 727 | 5445 | 0.1339 | -0.2802 |
MCF7 | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5118 | 5905 | 0.8669 | 0.8678 |
MCF7 | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3675 | 5445 | 0.6770 | 0.6408 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5969 | 5905 | 1.0110 | 1.0106 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1513 | 5445 | 0.2774 | 0.0419 |
MCF7 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4561 | 5445 | 0.8379 | 0.8267 |
MCF7 | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4722 | 5445 | 0.8668 | 0.8594 |
MCF7 | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4400 | 5445 | 0.8075 | 0.7926 |